SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

MDLN.O (MDLN.O) News

Follow MDLN.O (MDLN.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol MDLN.O Asset market Sector Markets 90 days 5 Updated Oct 15, 2026, 08:22 PM UTC Open live news feed
L Medline Director Joseph P. Baratta Resigns Effective Dec. 31, 2026 Joseph P. Baratta notified Medline's board on Oct. 13, 2026, that he will resign effective Dec. 31, 2026. His resignation coincides with his previously announced Blackstone departure, with no disagreement over company op REGULATION | Oct 15, 2026, 08:22 PM UTC L Medline plans 800,000 — square — foot distribution center in Michigan Medline plans a roughly 800,000-square-foot distribution center in Van Buren Township, Michigan, to expand its Midwest network. The facility is expected to begin serving Michigan customers in late 2028. The investment wi NEWS | Oct 15, 2026, 06:22 PM UTC L Medline signs prime vendor deal with South Carolina Pediatric Alliance Medline signed a prime vendor agreement with South Carolina Pediatric Alliance, a pediatric network formed by Palmetto Pediatrics and Sandhills Pediatrics. Deal gives the 10-location group access to Medline’s medical-sur NEWS | Oct 13, 2026, 02:45 PM UTC L GIC Private reports Medline common share sale worth $274.79 million GIC Private sold 7,816,987 Medline Class A shares on Oct. 8, 2026 at USD 35.15. Indirect stake held via Hux Investment fell to 69,408,506 shares following the sale. A separate direct holding was reported at 16,453,806 sh REGULATION | Oct 13, 2026, 01:26 PM UTC M Medline Inc. (MDLN) shares fall after FDA warning letter Medline shares fell about 12.8% to $36.67 on August 5, 2026, after the FDA published a warning letter detailing "significant violations of Current Good Manufacturing Practice regulations for finished pharmaceuticals." Th EQUITY | Oct 06, 2026, 02:02 PM UTC